XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $559 | +7.1% | 14,515 | -0.6% | 0.02% | 0.0% |
| Q1 2023 | $522 | -9.7% | 14,598 | -0.3% | 0.02% | -12.0% |
| Q4 2022 | $578 | -99.9% | 14,649 | -15.8% | 0.02% | +4.2% |
| Q3 2022 | $628,000 | -6.3% | 17,400 | -21.0% | 0.02% | +20.0% |
| Q2 2022 | $670,000 | -0.4% | 22,025 | -0.0% | 0.02% | +25.0% |
| Q1 2022 | $673,000 | -14.9% | 22,031 | -13.0% | 0.02% | 0.0% |
| Q4 2021 | $791,000 | +105.5% | 25,329 | +0.7% | 0.02% | +77.8% |
| Q3 2021 | $385,000 | -21.3% | 25,165 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $489,000 | +10.1% | 26,245 | +5.8% | 0.01% | 0.0% |
| Q1 2021 | $444,000 | – | 24,805 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |